Dechra Pharmaceuticals Ltd
Dechra Pharmaceuticals's GHG Emissions Data Preview
In 2023, Dechra Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Dechra Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 |
Total Scope 2 | ||||
Location-Based | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature.  a | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 | 0000000 |
Verified Sources Behind Dechra Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Dechra Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Dechra Pharmaceuticals's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Dechra Pharmaceuticals amounted to 10,994 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Dechra Pharmaceuticals decreased by 5.26%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
Dechra Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Dechra Pharmaceuticals's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Dechra Pharmaceuticals were 5,927 metric tons of CO₂ equivalent (tCO₂e).a
Has Dechra Pharmaceuticals reduced its Scope 1 emissions over time?
Since 2021, Dechra Pharmaceuticals's Scope 1 emissions have decreased by 15.65%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2022), Dechra Pharmaceuticals's Scope 1 emissions decreased by 11.66%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
What are Dechra Pharmaceuticals's Scope 2 emissions?
In 2023, Dechra Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 5,067 tCO₂e using the location-based method.a
Has Dechra Pharmaceuticals reduced its Scope 2 emissions over time?
Since 2021, Dechra Pharmaceuticals's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have remained relatively stable, indicating that Dechra Pharmaceuticals's emissions have plateaued with no significant change in its energy consumption footprint.a
Compared to the previous year (2022), Dechra Pharmaceuticals's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Dechra Pharmaceuticals's emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does Dechra Pharmaceuticals use for Scope 2 reporting?
In 2023, Dechra Pharmaceuticals reported its Scope 2 emissions using the location-based method.a
Dechra Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
Insights into Dechra Pharmaceuticals's Value Chain Emissions
In 2023, Dechra Pharmaceuticals reported 2,982 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2023 disclosure of Dechra Pharmaceuticals includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
Dechra Pharmaceuticals's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Dechra Pharmaceuticals's Scope 3 emissions?
In 2023, Dechra Pharmaceuticals reported total Scope 3 emissions of 2,982 metric tons of CO₂ equivalent (tCO₂e).a
Has Dechra Pharmaceuticals reduced its Scope 3 emissions over time?
Since 2021, Dechra Pharmaceuticals's Scope 3 emissions have increased by 54.19%, reflecting a rising long-term trend in Scope 3 emissions over time.a
Compared to the previous year (2022), Dechra Pharmaceuticals's Scope 3 emissions remained relatively stable, indicating that Dechra Pharmaceuticals's emissions have plateaued with no significant change in its value chain footprint.a
Insights into Dechra Pharmaceuticals's Total Carbon Footprint
In 2023, Dechra Pharmaceuticals reported a total carbon footprint of 13,976 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 2.78% decrease compared to 2022, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Dechra Pharmaceuticals's total carbon footprint was Scope 1 emissions, accounting for 42.41% of the company's total carbon footprint, followed by Scope 2 emissions at 36.26%.a